279 participants
External Control, Observational, Retrospective Study Comparing Pralsetinib to Best Available Therapy in Patients With RET-Fusion Positive NSCLC
- Study Type:
- OBSERVATIONAL
- Last Updated:
- 2021-08-10
- Start Date:
- 2020-12-01
- Completion:
- 2021-10-31
Conditions
- RET-fusion Non Small Cell Lung Cancer
- Lung Neoplasm
- Carcinoma, Non-Small-Cell Lung
- Respiratory Tract Neoplasms
- Thoracic Neoplasms
- Neoplasms by Site
- Neoplasms
- Lung Diseases
- Respiratory Tract Diseases
- Carcinoma, Bronchogenic
- Bronchial Diseases
- Head and Neck Neoplasms
- Carcinoma
- Neoplasms by Histologic Type
- Neoplasms, Germ Cell and Embryonal
- Neoplasms, Nerve Tissue
- Metastatic Non Small Cell Lung Cancer
No Results Yet